The Society for Immunotherapy of Cancer (SITC) hosted Session 107a during the 38th Annual Meeting & Pre-Conference Programs on Friday, November 3, 2023. Available here are the presentation slides and video from “Session 107a: Cytokines in Cancer” as permitted by presenters.
Warren Leonard, MD – National Institutes of Health
Ann Silk, MD, MS – Dana-Farber Cancer Institute
This session will cover the role of cytokines in tumor-immune interactions and how cytokines can play a role in clinical oncology. This is a rapidly expanding field, where engineered forms of cytokines and combination approaches are being extensively studied. Dr. Rafi Ahmed will provide insight into the mechanisms by which IL-2 combination therapy with PD-1 affects the CD8 T cell exhaustion program. Dr. Jamie Spangler will discuss novel engineered cytokines and immunocytokines. Dr. Karim Chamie will give a clinical perspective on the use of cytokines, including an engineered form of IL-15, in the treatment of patients with bladder cancer.
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Friday, November 301:55:39